nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Neutropenia—Chlorambucil—testicular cancer	0.00928	0.00928	CcSEcCtD
Entecavir—Hepatic failure—Dactinomycin—testicular cancer	0.00922	0.00922	CcSEcCtD
Entecavir—Body temperature increased—Carboplatin—testicular cancer	0.00867	0.00867	CcSEcCtD
Entecavir—Hepatic failure—Ifosfamide—testicular cancer	0.00845	0.00845	CcSEcCtD
Entecavir—Transaminases increased—Epirubicin—testicular cancer	0.00761	0.00761	CcSEcCtD
Entecavir—Serum creatinine increased—Epirubicin—testicular cancer	0.00753	0.00753	CcSEcCtD
Entecavir—Blood creatinine increased—Ifosfamide—testicular cancer	0.00711	0.00711	CcSEcCtD
Entecavir—Transaminases increased—Doxorubicin—testicular cancer	0.00704	0.00704	CcSEcCtD
Entecavir—Alopecia—Chlorambucil—testicular cancer	0.00702	0.00702	CcSEcCtD
Entecavir—Serum creatinine increased—Doxorubicin—testicular cancer	0.00697	0.00697	CcSEcCtD
Entecavir—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00676	0.00676	CcSEcCtD
Entecavir—Neutropenia—Dactinomycin—testicular cancer	0.0067	0.0067	CcSEcCtD
Entecavir—Hepatomegaly—Epirubicin—testicular cancer	0.00654	0.00654	CcSEcCtD
Entecavir—Haematuria—Bleomycin—testicular cancer	0.00653	0.00653	CcSEcCtD
Entecavir—Pancreatitis—Ifosfamide—testicular cancer	0.00644	0.00644	CcSEcCtD
Entecavir—Alopecia—Vinblastine—testicular cancer	0.00643	0.00643	CcSEcCtD
Entecavir—Anaphylactoid reaction—Etoposide—testicular cancer	0.0062	0.0062	CcSEcCtD
Entecavir—Leukopenia—Chlorambucil—testicular cancer	0.00619	0.00619	CcSEcCtD
Entecavir—Blood creatinine increased—Cisplatin—testicular cancer	0.00613	0.00613	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—testicular cancer	0.00605	0.00605	CcSEcCtD
Entecavir—Hyperglycaemia—Ifosfamide—testicular cancer	0.00592	0.00592	CcSEcCtD
Entecavir—Renal failure—Ifosfamide—testicular cancer	0.00575	0.00575	CcSEcCtD
Entecavir—Hepatitis—Dactinomycin—testicular cancer	0.00573	0.00573	CcSEcCtD
Entecavir—Glycosuria—Epirubicin—testicular cancer	0.00572	0.00572	CcSEcCtD
Entecavir—Leukopenia—Vinblastine—testicular cancer	0.00567	0.00567	CcSEcCtD
Entecavir—Infection—Chlorambucil—testicular cancer	0.00561	0.00561	CcSEcCtD
Entecavir—Haematuria—Ifosfamide—testicular cancer	0.00558	0.00558	CcSEcCtD
Entecavir—Pancreatitis—Cisplatin—testicular cancer	0.00555	0.00555	CcSEcCtD
Entecavir—Hepatobiliary disease—Ifosfamide—testicular cancer	0.00553	0.00553	CcSEcCtD
Entecavir—Alopecia—Bleomycin—testicular cancer	0.00543	0.00543	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—testicular cancer	0.00529	0.00529	CcSEcCtD
Entecavir—Hepatitis—Ifosfamide—testicular cancer	0.00525	0.00525	CcSEcCtD
Entecavir—Alopecia—Dactinomycin—testicular cancer	0.00507	0.00507	CcSEcCtD
Entecavir—Dyspepsia—Chlorambucil—testicular cancer	0.00497	0.00497	CcSEcCtD
Entecavir—Renal failure—Cisplatin—testicular cancer	0.00496	0.00496	CcSEcCtD
Entecavir—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00487	0.00487	CcSEcCtD
Entecavir—Fatigue—Chlorambucil—testicular cancer	0.00487	0.00487	CcSEcCtD
Entecavir—Neutropenia—Etoposide—testicular cancer	0.00485	0.00485	CcSEcCtD
Entecavir—Leukopenia—Bleomycin—testicular cancer	0.00479	0.00479	CcSEcCtD
Entecavir—Hepatobiliary disease—Cisplatin—testicular cancer	0.00477	0.00477	CcSEcCtD
Entecavir—Immune system disorder—Ifosfamide—testicular cancer	0.00475	0.00475	CcSEcCtD
Entecavir—Alopecia—Ifosfamide—testicular cancer	0.00464	0.00464	CcSEcCtD
Entecavir—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00461	0.00461	CcSEcCtD
Entecavir—Mental disorder—Ifosfamide—testicular cancer	0.0046	0.0046	CcSEcCtD
Entecavir—Malnutrition—Ifosfamide—testicular cancer	0.00457	0.00457	CcSEcCtD
Entecavir—Renal failure—Etoposide—testicular cancer	0.00454	0.00454	CcSEcCtD
Entecavir—Leukopenia—Dactinomycin—testicular cancer	0.00447	0.00447	CcSEcCtD
Entecavir—Abdominal pain—Chlorambucil—testicular cancer	0.00446	0.00446	CcSEcCtD
Entecavir—Body temperature increased—Chlorambucil—testicular cancer	0.00446	0.00446	CcSEcCtD
Entecavir—Hepatobiliary disease—Etoposide—testicular cancer	0.00437	0.00437	CcSEcCtD
Entecavir—Anaphylactic shock—Bleomycin—testicular cancer	0.00437	0.00437	CcSEcCtD
Entecavir—Infection—Bleomycin—testicular cancer	0.00434	0.00434	CcSEcCtD
Entecavir—Gastrointestinal pain—Vinblastine—testicular cancer	0.00423	0.00423	CcSEcCtD
Entecavir—Leukopenia—Ifosfamide—testicular cancer	0.00409	0.00409	CcSEcCtD
Entecavir—Immune system disorder—Cisplatin—testicular cancer	0.00409	0.00409	CcSEcCtD
Entecavir—Abdominal pain—Vinblastine—testicular cancer	0.00409	0.00409	CcSEcCtD
Entecavir—Asthenia—Chlorambucil—testicular cancer	0.00405	0.00405	CcSEcCtD
Entecavir—Infection—Dactinomycin—testicular cancer	0.00405	0.00405	CcSEcCtD
Entecavir—Alopecia—Cisplatin—testicular cancer	0.004	0.004	CcSEcCtD
Entecavir—Hepatic failure—Methotrexate—testicular cancer	0.004	0.004	CcSEcCtD
Entecavir—Malnutrition—Cisplatin—testicular cancer	0.00394	0.00394	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00387	0.00387	CcSEcCtD
Entecavir—Diarrhoea—Chlorambucil—testicular cancer	0.00386	0.00386	CcSEcCtD
Entecavir—Immune system disorder—Etoposide—testicular cancer	0.00375	0.00375	CcSEcCtD
Entecavir—Hepatic failure—Epirubicin—testicular cancer	0.00374	0.00374	CcSEcCtD
Entecavir—Anaphylactic shock—Ifosfamide—testicular cancer	0.00373	0.00373	CcSEcCtD
Entecavir—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00371	0.00371	CcSEcCtD
Entecavir—Asthenia—Vinblastine—testicular cancer	0.00371	0.00371	CcSEcCtD
Entecavir—Infection—Ifosfamide—testicular cancer	0.00371	0.00371	CcSEcCtD
Entecavir—Alopecia—Etoposide—testicular cancer	0.00367	0.00367	CcSEcCtD
Entecavir—Nervous system disorder—Ifosfamide—testicular cancer	0.00366	0.00366	CcSEcCtD
Entecavir—Skin disorder—Ifosfamide—testicular cancer	0.00363	0.00363	CcSEcCtD
Entecavir—Vomiting—Chlorambucil—testicular cancer	0.00359	0.00359	CcSEcCtD
Entecavir—Diarrhoea—Vinblastine—testicular cancer	0.00354	0.00354	CcSEcCtD
Entecavir—Leukopenia—Cisplatin—testicular cancer	0.00353	0.00353	CcSEcCtD
Entecavir—Fatigue—Dactinomycin—testicular cancer	0.00351	0.00351	CcSEcCtD
Entecavir—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00347	0.00347	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—testicular cancer	0.00346	0.00346	CcSEcCtD
Entecavir—Body temperature increased—Bleomycin—testicular cancer	0.00345	0.00345	CcSEcCtD
Entecavir—Dizziness—Vinblastine—testicular cancer	0.00342	0.00342	CcSEcCtD
Entecavir—Nausea—Chlorambucil—testicular cancer	0.00335	0.00335	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00333	0.00333	CcSEcCtD
Entecavir—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00333	0.00333	CcSEcCtD
Entecavir—Somnolence—Ifosfamide—testicular cancer	0.00332	0.00332	CcSEcCtD
Entecavir—Vomiting—Vinblastine—testicular cancer	0.00329	0.00329	CcSEcCtD
Entecavir—Headache—Vinblastine—testicular cancer	0.00324	0.00324	CcSEcCtD
Entecavir—Leukopenia—Etoposide—testicular cancer	0.00323	0.00323	CcSEcCtD
Entecavir—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00322	0.00322	CcSEcCtD
Entecavir—Body temperature increased—Dactinomycin—testicular cancer	0.00322	0.00322	CcSEcCtD
Entecavir—Abdominal pain—Dactinomycin—testicular cancer	0.00322	0.00322	CcSEcCtD
Entecavir—Fatigue—Ifosfamide—testicular cancer	0.00322	0.00322	CcSEcCtD
Entecavir—Anaphylactic shock—Cisplatin—testicular cancer	0.00322	0.00322	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00321	0.00321	CcSEcCtD
Entecavir—Infection—Cisplatin—testicular cancer	0.0032	0.0032	CcSEcCtD
Entecavir—Nervous system disorder—Cisplatin—testicular cancer	0.00316	0.00316	CcSEcCtD
Entecavir—Blood creatinine increased—Epirubicin—testicular cancer	0.00315	0.00315	CcSEcCtD
Entecavir—Asthenia—Bleomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Entecavir—Skin disorder—Cisplatin—testicular cancer	0.00313	0.00313	CcSEcCtD
Entecavir—Nausea—Vinblastine—testicular cancer	0.00307	0.00307	CcSEcCtD
Entecavir—Abdominal pain upper—Epirubicin—testicular cancer	0.00307	0.00307	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00305	0.00305	CcSEcCtD
Entecavir—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00305	0.00305	CcSEcCtD
Entecavir—Pancreatitis—Methotrexate—testicular cancer	0.00304	0.00304	CcSEcCtD
Entecavir—Abdominal pain—Ifosfamide—testicular cancer	0.00295	0.00295	CcSEcCtD
Entecavir—Body temperature increased—Ifosfamide—testicular cancer	0.00295	0.00295	CcSEcCtD
Entecavir—Anaphylactic shock—Etoposide—testicular cancer	0.00295	0.00295	CcSEcCtD
Entecavir—Infection—Etoposide—testicular cancer	0.00293	0.00293	CcSEcCtD
Entecavir—Asthenia—Dactinomycin—testicular cancer	0.00292	0.00292	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—testicular cancer	0.00291	0.00291	CcSEcCtD
Entecavir—Neutropenia—Methotrexate—testicular cancer	0.0029	0.0029	CcSEcCtD
Entecavir—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00289	0.00289	CcSEcCtD
Entecavir—Skin disorder—Etoposide—testicular cancer	0.00286	0.00286	CcSEcCtD
Entecavir—Pancreatitis—Epirubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—testicular cancer	0.00284	0.00284	CcSEcCtD
Entecavir—Diarrhoea—Dactinomycin—testicular cancer	0.00279	0.00279	CcSEcCtD
Entecavir—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00278	0.00278	CcSEcCtD
Entecavir—Vomiting—Bleomycin—testicular cancer	0.00278	0.00278	CcSEcCtD
Entecavir—Rash—Bleomycin—testicular cancer	0.00275	0.00275	CcSEcCtD
Entecavir—Dermatitis—Bleomycin—testicular cancer	0.00275	0.00275	CcSEcCtD
Entecavir—Renal failure—Methotrexate—testicular cancer	0.00272	0.00272	CcSEcCtD
Entecavir—Neutropenia—Epirubicin—testicular cancer	0.00272	0.00272	CcSEcCtD
Entecavir—Upper respiratory tract infection—Epirubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Entecavir—Asthenia—Ifosfamide—testicular cancer	0.00268	0.00268	CcSEcCtD
Entecavir—Haematuria—Methotrexate—testicular cancer	0.00264	0.00264	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Entecavir—Hyperglycaemia—Epirubicin—testicular cancer	0.00262	0.00262	CcSEcCtD
Entecavir—Somnolence—Etoposide—testicular cancer	0.00262	0.00262	CcSEcCtD
Entecavir—Hepatobiliary disease—Methotrexate—testicular cancer	0.00262	0.00262	CcSEcCtD
Entecavir—Nausea—Bleomycin—testicular cancer	0.00259	0.00259	CcSEcCtD
Entecavir—Vomiting—Dactinomycin—testicular cancer	0.00259	0.00259	CcSEcCtD
Entecavir—Rash—Dactinomycin—testicular cancer	0.00257	0.00257	CcSEcCtD
Entecavir—Diarrhoea—Ifosfamide—testicular cancer	0.00255	0.00255	CcSEcCtD
Entecavir—Renal failure—Epirubicin—testicular cancer	0.00255	0.00255	CcSEcCtD
Entecavir—Gastrointestinal disorder—Etoposide—testicular cancer	0.00255	0.00255	CcSEcCtD
Entecavir—Body temperature increased—Cisplatin—testicular cancer	0.00254	0.00254	CcSEcCtD
Entecavir—Fatigue—Etoposide—testicular cancer	0.00254	0.00254	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—testicular cancer	0.00251	0.00251	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.0025	0.0025	CcSEcCtD
Entecavir—Hepatitis—Methotrexate—testicular cancer	0.00249	0.00249	CcSEcCtD
Entecavir—Haematuria—Epirubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Entecavir—Dizziness—Ifosfamide—testicular cancer	0.00247	0.00247	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Entecavir—Nausea—Dactinomycin—testicular cancer	0.00242	0.00242	CcSEcCtD
Entecavir—Gastrointestinal pain—Etoposide—testicular cancer	0.00241	0.00241	CcSEcCtD
Entecavir—Vomiting—Ifosfamide—testicular cancer	0.00237	0.00237	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Entecavir—Rash—Ifosfamide—testicular cancer	0.00235	0.00235	CcSEcCtD
Entecavir—Dermatitis—Ifosfamide—testicular cancer	0.00235	0.00235	CcSEcCtD
Entecavir—Abdominal pain—Etoposide—testicular cancer	0.00233	0.00233	CcSEcCtD
Entecavir—Body temperature increased—Etoposide—testicular cancer	0.00233	0.00233	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—testicular cancer	0.00233	0.00233	CcSEcCtD
Entecavir—Asthenia—Cisplatin—testicular cancer	0.00231	0.00231	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—testicular cancer	0.00229	0.00229	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—testicular cancer	0.00229	0.00229	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Entecavir—Immune system disorder—Methotrexate—testicular cancer	0.00224	0.00224	CcSEcCtD
Entecavir—Nausea—Ifosfamide—testicular cancer	0.00222	0.00222	CcSEcCtD
Entecavir—Diarrhoea—Cisplatin—testicular cancer	0.0022	0.0022	CcSEcCtD
Entecavir—Alopecia—Methotrexate—testicular cancer	0.0022	0.0022	CcSEcCtD
Entecavir—Mental disorder—Methotrexate—testicular cancer	0.00218	0.00218	CcSEcCtD
Entecavir—Malnutrition—Methotrexate—testicular cancer	0.00216	0.00216	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—testicular cancer	0.00212	0.00212	CcSEcCtD
Entecavir—Asthenia—Etoposide—testicular cancer	0.00212	0.00212	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Entecavir—Alopecia—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Entecavir—Vomiting—Cisplatin—testicular cancer	0.00205	0.00205	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—testicular cancer	0.00204	0.00204	CcSEcCtD
Entecavir—Rash—Cisplatin—testicular cancer	0.00203	0.00203	CcSEcCtD
Entecavir—Dermatitis—Cisplatin—testicular cancer	0.00203	0.00203	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Entecavir—Diarrhoea—Etoposide—testicular cancer	0.00202	0.00202	CcSEcCtD
Entecavir—Dizziness—Etoposide—testicular cancer	0.00195	0.00195	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Entecavir—Leukopenia—Methotrexate—testicular cancer	0.00194	0.00194	CcSEcCtD
Entecavir—Nausea—Cisplatin—testicular cancer	0.00191	0.00191	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Entecavir—Vomiting—Etoposide—testicular cancer	0.00187	0.00187	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Entecavir—Rash—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Entecavir—Dermatitis—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Entecavir—Headache—Etoposide—testicular cancer	0.00185	0.00185	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00183	0.00183	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Entecavir—Anaphylactic shock—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Entecavir—Infection—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Entecavir—Nausea—Etoposide—testicular cancer	0.00175	0.00175	CcSEcCtD
Entecavir—Nervous system disorder—Methotrexate—testicular cancer	0.00173	0.00173	CcSEcCtD
Entecavir—Skin disorder—Methotrexate—testicular cancer	0.00172	0.00172	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Entecavir—Infection—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Entecavir—Insomnia—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Entecavir—Somnolence—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Entecavir—Dyspepsia—Methotrexate—testicular cancer	0.00155	0.00155	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Entecavir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Entecavir—Fatigue—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Entecavir—Infection—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Entecavir—Insomnia—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Entecavir—Somnolence—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Entecavir—Gastrointestinal pain—Methotrexate—testicular cancer	0.00144	0.00144	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Entecavir—Fatigue—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Entecavir—Abdominal pain—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Entecavir—Body temperature increased—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Entecavir—Asthenia—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Entecavir—Diarrhoea—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Entecavir—Asthenia—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Entecavir—Dizziness—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Entecavir—Vomiting—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Entecavir—Rash—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Entecavir—Dermatitis—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Entecavir—Headache—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Entecavir—Dizziness—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Entecavir—Vomiting—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Entecavir—Nausea—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Entecavir—Rash—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Entecavir—Headache—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Entecavir—Nausea—Epirubicin—testicular cancer	0.000982	0.000982	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—testicular cancer	0.000972	0.000972	CcSEcCtD
Entecavir—Rash—Doxorubicin—testicular cancer	0.000964	0.000964	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—testicular cancer	0.000963	0.000963	CcSEcCtD
Entecavir—Headache—Doxorubicin—testicular cancer	0.000958	0.000958	CcSEcCtD
Entecavir—Nausea—Doxorubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
